期刊文献+

鸡骨保护素在毕赤酵母中的分泌表达及生物学活性测定

Secreting expression of chicken osteoprotegerin (chOPG) in Pichia pastoris and the bioactivity of recombinant protein
下载PDF
导出
摘要 为了在毕赤酵母中表达鸡骨保护素(chOPG),采用DNA重组技术将鸡OPG成熟肽cDNA片段插入毕赤酵母表达载体pPICZα-A中,以电穿孔法转化酵母X-33,用Zeoc in平板筛选阳性重组子,经甲醇诱导,实现了OPG在毕赤酵母中的分泌表达。SDS-PAGE电泳分析结果显示,表达产物存在两种形式,其相对分子质量分别为43000和53000,表达量约为200 mg.L-1,经免疫印迹验证,有较好的抗原性。表达产物经处理后加入到体外培养的鸡胚破骨细胞上,能显著抑制成熟破骨细胞的骨吸收活性,减少骨吸收陷窝的个数与面积。 To express chicken osteoprotegerin (chOPG) in Pichia pastoris and determine its inhibitive effects on mature osteoclastic bone resorptive function in vitro, the chOPG cDNA encoding for 382 amino acid without signal peptide was subcloned into Pichia pastoris expression vector pPICZα-A. The constructed recombinant plasmid was transformed into yeast host cell X-33 by electropora- tion. The positive recombinant transformants were selected with PCR from Zeocin YPDS plate. Induced by the addition of methanol every 24 hours, mainly owing to heterogeneous glycosylation, the product relative moleculer mass was about 43 000 and 53 000 respectively at a yield of 200 mg per litter of culture. The result of Western-blot indicated that the recombinant protein had specific antigenicity. The chOPG recombinant protein at certain concentration could restrain the activity of mature osteoclasts in vitro, that is to say, the number and area of the bone resorptive lacunae both decreased.
出处 《南京农业大学学报》 CAS CSCD 北大核心 2009年第2期88-91,共4页 Journal of Nanjing Agricultural University
基金 国家自然科学基金项目(30671546) 教育部重点项目(107059) 江苏省自然科学基金项目(BK2004099)
关键词 鸡骨保护素 毕赤酵母 分泌表达 破骨细胞 chicken osteoprotegerin Pichia pastoris secretive expression osteoclast
  • 相关文献

参考文献15

  • 1Simonet W S, Lacey D L, Dunstan C R, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density [J]. Cell, 1997, 89(2): 309-319. 被引量:1
  • 2Yasuda H, Shima N, Nakagawa N, et al. Identity of osteoclastogenesis inhibitory, factor(OCIF) and osteoprotegerin(OPG) : a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro [J]. Endocrinology, 1998, 139(3) : 1329 - 1337. 被引量:1
  • 3Tan K B, Harrop J, Reddy M, et al. Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells [ J]. Gene, 1997, 204:35 -46. 被引量:1
  • 4Kwon B S, Wang S, Udagawa N, et al. TR1, a new member of the tumor necrosis factor receptor family, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption [ J]. FASEB, 1998, 12:845 -854. 被引量:1
  • 5Yun T J, Chaudhau P M, Shu G L, et al. OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40 [J]. J Immunol, 1998. 161 : 6113 -6121. 被引量:1
  • 6刘继中,陈苏民,李毅,胡蕴玉,纪宗玲,杨彤涛.人骨保护素在毕赤酵母中的分泌表达及表达产物的生物活性分析(英文)[J].中国生物化学与分子生物学报,2003,19(5):566-571. 被引量:2
  • 7王宝利,戴芳,郭刚,邱明才,张镜宇.人骨保护素成熟肽表达载体的构建、表达及重组蛋白免疫学鉴定[J].天津医药,2003,31(11):691-693. 被引量:3
  • 8姚静,邓益锋,周振雷,侯加法.鸡骨保护素(chOPG)编码区基因的克隆和序列分析[J].农业生物技术学报,2006,14(5):816-817. 被引量:5
  • 9Cregg J M, Cereghine J L, Shi J, et al. Recombinant protein expression in Pichia pastoris [J]. Mol Biotechnol, 2000, 16(1 ) : 23 -52. 被引量:1
  • 10萨姆布鲁克 J,弗里奇 E F,曼尼阿蒂斯芬 T.分子克隆实验指南[M].金冬雁,黎孟枫,译.2版.北京:科学出版社,1998. 被引量:19

二级参考文献55

  • 1张皎,侯加法.依普拉芬对鸡胚成骨细胞的增殖和分化的影响[J].中国骨质疏松杂志,2004,10(2):236-238. 被引量:12
  • 2程志强,蔡军,蔡芳,赵崇,张镜宇,张连祥,张建民,郑翠英.适于临床PCR法基因检测的血样处理[J].天津医科大学学报,1996,2(2):18-20. 被引量:14
  • 3黄培堂译(Joseph Sambrook David W.Russell著).分子克隆实验指南.第3版[M].北京:科学出版社,2002.610-1. 被引量:1
  • 4Linder S,Schliwa M, Kube-Granderath E. Direct PCR screening of pichia pastoris clones. Biotechniques, 1996,20(6) : 980--2. 被引量:1
  • 5Hoffman CS, Winston F. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene, 1987,57(2-3) : 267--72. 被引量:1
  • 6Simonet W S, Lacey D L, Dunstan C R, Kelley M, Chang M S, Luthy R, Nguyen H Q, Wooden S, Bennett L, Boone T, Shimmamoto G. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 1997, 89(2):309-319. 被引量:1
  • 7Yasuda H, Shima N, Nakagawa N, Mochizuki SI, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, Higashio K. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotogerin (OPG) : a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology ,1998,139(3) : 1329 - 1337. 被引量:1
  • 8Rodan G A, Martin T J. Therapeutic Approaches to Bone diseases Science , 2000, 289:1508 - 1514. 被引量:1
  • 9Bekker P J, Holloway D, Nakanishi A, Arrighi M, Leese P T, Dunstan C R. The effect of a single dose of osteoprotegerin in postmenopausal women. J Bone Miner Res. 2001, 16(2) :348 - 360. 被引量:1
  • 10Yamaguchi K, Kinosaki M, Goto M, Kobayashi F, Tsuda E, Morinaga T, Higashio K. Characterization of structural domains of human osteoclastogenesis inhibitory factor. J Biol Chem, 1998, 273 (9) :5117- 5123. 被引量:1

共引文献274

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部